The term “over-diagnosis” didn’t exist 15 years ago in the management of prostate cancer. (Well, actually it did, but it would very rarely — if ever — have come to the notice of any patient or even of the average urologist or primary care physician.) … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Management, over-diagnosis, risk | 5 Comments »
There is an interesting new article just published in the Journal of the National Cancer Institute describing a nomogram designed to estimate risk for over-diagnosis of men diagnosed with prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, nomogram, over-diagnosis, over-treatment, risk | 4 Comments »
The potential problems associated with over-diagnosis and over-treatment that have been much debated in the world of prostate cancer over the past few years actually go well beyond prostate cancer. … READ MORE ..
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: over-diagnosis, over-treatment, risk | 9 Comments »
A conversation between two extremely knowledgeable prostate cancer advocates in comments on an earlier post has highlighted the underlying problem of what we mean by “over-diagnosis” and “over-treatment” of prostate cancer in a highly educational manner. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: over-diagnosis, over-treatment, risk | 9 Comments »
Science Daily has now provided more detailed information (and a more accurate perspective) on the study by Draisma et al., entitled, “Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.” As of 9:10 am EST this morning, the actual content of this article is still not available on line. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: lead time, over-diagnosis, screening | 10 Comments »
